Drug-maker Cipla today said it has appointed Subhanu Saxena as the chief executive officer of the company.The appointment is effective from February 1, 2013.Saxena has more than 25 years of work......
Novartis AG expects India to capture a chunk of the $1 billion investment in software development and IT projects that its undertakes globally every year.The global drug major's Indian arm,......
The $25 billion Novartis AG has identified 'alliance model' as its growth strategy in India. The Swiss drug maker is exploring collaborations with Indian pharmaceutical companies in all possible......
Prospects of an interest rate cut by the RBI at its forthcoming monetary policy review spurted buying across the board. Markets rebounded to end with strong gains amid a rally in global stocks......
Emerging markets, from South Africa to China and India, are battling to bring down healthcare costs. Global pharmaceutical firms are pressuring the United States to act against India to stop more......